Intravenous Immunoglobulin Market by Component (IgG, IgA, IgM, IgE, and IgD), by Application (Immunodeficiency Diseases, Chronic Inflammatory Demyelinating Polyneuropathy, Myasthenia Gravis, Idiopathic Thrombocytopenic Purpura, Hypogammaglobulinemia, Multifocal Motor Neuropathy, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-Barre Syndrome, and Others), and by End-User (Hospitals, Clinics, and Homecare Settings)-Global Industry Analytics, COVID-19 Business Impact, and Trends, 2020–2029

                                          
Abstract
                    
The report covers a forecast and an analysis of the global intravenous immunoglobulin market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes the drivers and restraints of the intravenous immunoglobulin market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in intravenous immunoglobulin market on a global level.

In order to give the users of this report a comprehensive view of the intravenous immunoglobulin market, we have included a competitive landscape and an analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations &joint ventures, research and development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the intravenous immunoglobulin market by component, application, end-user, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Some major players of the global intravenous immunoglobulin market are LFB Biotechnologies, Biotest, Octapharma, Grifols, CSL Behring, China Biologics Products, Kedrion Biopharma, BDI Pharma, Shire, and CSL Behring.

This report segments the global intravenous immunoglobulin market into:

Global Intravenous Immunoglobulin Market: Component Analysis

	IgG
	IgA
	IgM
	IgE
	IgD

Global Intravenous Immunoglobulin Market: Application Analysis

	Immunodeficiency Diseases
	Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
	Idiopathic Thrombocytopenic Purpura
	Hypogammaglobulinemia
	Myasthenia Gravis
	Multifocal Motor Neuropathy
	Inflammatory Myopathies
	Specific Antibody Deficiency
	Guillain-Barre Syndrome
	Others

Global Intravenous Immunoglobulin Market: End-User Analysis

	Hospitals
	Clinics
	Homecare Settings

Global Intravenous Immunoglobulin Market: Regional Analysis

	North America
	
		The U.S.
	
	
	Europe
	
		UK
		France
		Germany
	
	
	Asia Pacific
	
		China
		Japan
		India
	
	
	Latin America
	
		Brazil
	
	
	Middle East and Africa